Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Revenue (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Revenue for 11 consecutive years, with $8.7 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Revenue fell 55.82% year-over-year to $8.7 million, compared with a TTM value of $17.9 million through Dec 2025, down 44.54%, and an annual FY2025 reading of $42.7 million, down 60.55% over the prior year.
  • Revenue was $8.7 million for Q2 2025 at Wave Life Sciences, down from $9.2 million in the prior quarter.
  • Across five years, Revenue topped out at $49.2 million in Q3 2023 and bottomed at $285000.0 in Q3 2022.
  • Average Revenue over 5 years is $13.9 million, with a median of $9.2 million recorded in 2025.
  • The sharpest move saw Revenue crashed 99.22% in 2022, then soared 17168.07% in 2023.
  • Year by year, Revenue stood at $1.8 million in 2021, then dropped by 29.8% to $1.2 million in 2022, then skyrocketed by 2245.12% to $29.1 million in 2023, then tumbled by 32.23% to $19.7 million in 2024, then crashed by 55.82% to $8.7 million in 2025.
  • Business Quant data shows Revenue for WVE at $8.7 million in Q2 2025, $9.2 million in Q1 2025, and $19.7 million in Q2 2024.